. "Li S, Pal R, Monaghan SA, et al. IMiD immunomodulatory compounds block C/EBPβ translation through eIF4E down-regulation resulting in inhibition of MM.
                    <i>Blood</i>
                    . 2011;117(19):5157-5165.." Blood, 2026. doi:10.1182/blood.2026033419